483
Sichuan Qingmu Pharmaceutical Co., LtdFDA 483 - Sichuan Qingmu Pharmaceutical Co., Ltd - October 24, 2025
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Record Details
An FDA inspection of Sichuan Qingmu Pharmaceutical Co. Ltd., an API manufacturer in Meishan City, China, from October 20-24, 2025, identified one observation. The firm was cited for not maintaining adequate records associated with the receiving of raw materials, specifically lacking a chronological and sequential receiving log. This indicates a deficiency in their paper-based material management system.
Open in Dashboard
ID · 56086bde-0559-4711-9668-3b5af53c6726